Drug intelligence / Profile preview

VRP-048

Development stage
Preclinical
Lead developer
Venus Medicine Research Centre
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Oral
01

Overview

VRP-048 is a preclinical-stage oral combination therapy developed by Venus Medicine Research Centre (VMRC) for the treatment of bacterial infections, particularly those involving antimicrobial resistance (AMR). The drug candidate combines meropenem, a broad-spectrum carbapenem antibiotic, with MET-X, a proprietary antibiotic resistance breaker (ARB). VRP-048 utilizes VMRC's Stealth Targeted Nanoparticles (STN) platform, which is engineered to facilitate the oral delivery of BCS Class III and IV antibiotics that are typically restricted to intravenous administration. By pairing a potent antibiotic with a resistance-breaking component in a specialized nanoparticle delivery system, VRP-048 aims to provide an effective oral alternative for managing multi-drug resistant bacterial infections.

Other names
meropenem + MET-X
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on VRP-048.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VRP-048.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call